Highest development stage: Phase 3

Development status: Inactive

Gram-positive activity

Gram-negative activity

Mechanism of Action/Target pathogen: Use against CAP and gastrointestinal infections. Spectinomycin analog with greater potency than its parent molecule

Additional information: Novak, E., et al. "Safety and preliminary pharmacokinetics of intravenously administered trospectomycin sulfate (U-63,366 F) in man: a novel spectinomycin analogue [abstr 271]." 27th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). 1987.